Product Information
TAZAROTENE 0.05% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $6.6453 per GM under NDC 45802070694. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802070694
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
TAZAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA217075On Market Since
9/9/2024
Pharmacological Classes
Price Statistics
The NADAC for TAZAROTENE 0.05% CREAM has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6453 per GM |
|---|---|
| All-time high | $10.7939 (May 14, 2025) |
| All-time low | $6.6453 (Jun 17, 2026) |
| 52-week high | $10.4772 |
| 52-week low | $6.6453 |
| Median price | $9.2719 |
| Average price | $9.1421 |
| Largest weekly change | -8.3% (Oct 22, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TAZAROTENE 0.05% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.05% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $6.6453 per GM (NDC 45802070694), effective Jun 24, 2026.
How has the price of TAZAROTENE 0.05% CREAM changed over time?
Over the history we have for it, the NADAC for TAZAROTENE 0.05% CREAM has declined 35.8%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.05% CREAM?
Since Dec 18, 2024, the NADAC for TAZAROTENE 0.05% CREAM has ranged from a low of $6.6453 (Jun 17, 2026) to a high of $10.7939 (May 14, 2025), with a median of $9.2719 per GM.
Are there cheaper alternatives to TAZAROTENE 0.05% CREAM?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TAZAROTENE 0.05% GEL, is $5.8205 per GM — about 12% below TAZAROTENE 0.05% CREAM.
Who manufactures TAZAROTENE 0.05% CREAM?
TAZAROTENE 0.05% CREAM (NDC 45802070694) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification